ALDX SECURITIES UPDATE: Aldeyra Therapeutics Investors with Losses may have been affected by Securities Violations – Contact BFA Law (NASDAQ:ALDX) — Neutral
ALDX GlobeNewsWire — May 07, 2025NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for potential violations of the federal securities laws. If you invested in Aldeyra Therapeutics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/aldeyra-therapeutics-inc.

Arq, Inc. (ARQ) Reports Break-Even Earnings for Q1 — Neutral
ARQ Zacks Investment Research — May 07, 2025Arq, Inc. (ARQ) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.09 per share a year ago.

Perrigo (PRGO) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.29 per share a year ago.

Kennametal (KMT) Beats Q3 Earnings Estimates — Positive
KMT Zacks Investment Research — May 07, 2025Kennametal (KMT) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.30 per share a year ago.

QIAGEN to Propose Initiation of Annual Cash Dividend for Shareholder Approval at Annual General Meeting — Neutral
QGEN Business Wire — May 07, 2025VENLO, the Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its Supervisory Board will propose the initiation of an annual cash dividend under an amended dividend policy to QIAGEN's shareholders at the next Annual General Meeting scheduled for June 26, 2025. This milestone reflects QIAGEN's strategy to introduce a new avenue to increase shareholder returns while preserving flexibility to reinvest in long-term growth. The Supervisory Boar.

NeuroSense Therapeutics Announces Successful Completion of Commercial Manufacturing Scale-Up for PrimeC in Preparation for Potential Canadian Market Launch — Neutral
NRSN PRNewsWire — May 07, 2025NeuroSense Announces Global CDMO Selection and Manufacturing Scale-Up, Enabling Rapid Pathway to Commercialization for What is Projected to be a $100-150M Canadian Market Opportunity CAMBRIDGE, Mass. , May 7, 2025 /PRNewswire/ -- NeuroSense Therapeutics Ltd.

Buy-Side Technology Enables Transparent Media Buying Across Full Open Internet Inventory Buy-Side Technology Enables Transparent Media Buying Across Full Open Internet Inventory

LONDON, May 07, 2025 (GLOBE NEWSWIRE) -- Navigator Holdings Ltd. (described herein as “Navigator Gas” or the “Company”) (NYSE: NVGS), the owner and operator of the world's largest fleet of handysize liquefied gas carriers, announces the publication of its 2024 Sustainability Report.

INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients — Neutral
IINN GlobeNewsWire — May 07, 2025RA'ANANA, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that the INSPIRA™ ART100 has been approved by Israel's largest healthcare provider to undergo a clinical validation by leading physicians who intend to use the innovative life-support and diagnostic device during organ transplant procedures. As part of this advancement, Inspira will deploy the U.S. Food and Drug Administration (“FDA”) approved INSPIRA ART100 system at one of Israel's renowned medical centers affiliated with the largest health care provider.

OS Therapies Announces Issuance of U.S. Patent #12,239,738 Protecting Commercial Manufacturing Market Exclusivity for OST-HER2 in Rare Pediatric Cancer Osteosarcoma and Full Listeria Cancer Immunotherapy Platform into 2040 — Neutral
OSTX Business Wire — May 07, 2025NEW YORK--(BUSINESS WIRE)--OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced the issuance of United States Patent #12,230,738 protecting proprietary commercial manufacturing methods for the Company's listeria monocytogenes (Lm) cancer immunotherapy platform technology into 2040. The Company is seeking to gain FDA approval for lead asset OST-HER2 in the treatment of pediatric.

Venu Holding Corporation Partners with Sands Investment Group for Nationwide NNN Luxe FireSuite Real Estate Opportunity — Neutral
VENU Business Wire — May 07, 2025COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Venu Holding Corporation ("VENU" or the “Company”) (NYSE American: VENU), a developer, owner, and operator of upscale live music venues and premium hospitality destinations, today announced its official partnership with Sands Investment Group (“SIG”), one of the nation's fastest-growing net lease companies, to offer innovative NNN real estate opportunities by way of VENU's most sought after investment opportunities, Luxe FireSuites, located within its p.

SEATTLE--(BUSINESS WIRE)--F5, Inc. (NASDAQ: FFIV), F5 (FFIV), the global leader in delivering and securing every app and API, today announced that it will participate in the 53rd Annual J.P. Morgan Global Technology, Media and Communications Conference. F5's presentation will be webcast live on Wednesday, May 14, 2025 at 10:40 a.m. ET. Interested attendees can access the live webcast via the Events & Presentations tab within the Investor Relations section of f5.com or via this link. An arch.

CLASS ACTION NOTICE: Berger Montague Advises Open Lending Corporation (NASDAQ: LPRO) Investors to Inquire About a Securities Fraud Class Action — Neutral
LPRO PRNewsWire — May 07, 2025PHILADELPHIA , May 7, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Open Lending Corporation ("Open Lending" or the "Company") (NASDAQ: LPRO) on behalf of purchasers of Open Lending securities between February 24, 2022 through March 31, 2025, inclusive (the "Class Period"). Investor Deadline: Investors who purchased or acquired Open Lending securities during the Class Period may, no later than JUNE 30, 2025 , seek to be appointed as a lead plaintiff representative of the class.

Meta's new AI chatbot is yet another tool for harvesting data to potentially sell you stuff — Neutral
META TechXplore — May 07, 2025Last week, Meta—the parent company of Facebook, Instagram, Threads and WhatsApp—unveiled a new "personal artificial intelligence (AI)."

Marvell's stock is falling. Here's why investors are spooked. — Negative
MRVL Market Watch — May 07, 2025The semiconductor company just postponed its investor day, suggesting to one analyst that “there is not too much good news to share.”

AMZN, AAPL and NFLX Forecast – Major US Stocks Waiting for FOMC — Positive
AAPL AMZN NFLX FXEmpire — May 07, 2025The announcements coming out of the Federal Reserve later in the session will have an influence on where we go next in these major stocks, but so far, it looks like they are trying to rally, mainly on the back of the announcement of US/China talks.

Disney stock rises as earnings beat market expectations — Positive
DIS Proactive Investors — May 07, 2025Shares in Walt Disney Co (NYSE:DIS, ETR:WDP) gained over 8% in Wednesday's premarket after reporting second-quarter results that exceeded Wall Street expectations, Moreover, the Mouse House upgraded its full-year earnings forecast. Revenue for the three-months was up 7% year-on-year, to US$23.62 billion, and adjusted earnings per share climbed 20% to US$1.45.

90% of Parents Report High-Quality Child Care Improves Their Well-Being — Neutral
KLC Business Wire — May 07, 2025LAKE OSWEGO, ORE.--(BUSINESS WIRE)--Recent data from KinderCare Learning Companies, Inc.'s (NYSE: KLC) (“KinderCare”) sixth annual KinderCare Confidence Index, a national study conducted in partnership with The Harris Poll, found that access to quality child care is a critical cornerstone to enhancing parental well-being and mental health. Parents report unprecedented levels of stress and anxiety in pursuit of "perfect parenting.” Parents also said access to high-quality child care greatly impr.

CRISPR Therapeutics Q1 Earnings and Sales Miss Estimates, Stock Tanks — Negative
CRSP Zacks Investment Research — May 07, 2025CRSP reports wider-than-expected first-quarter loss. Revenues also miss estimates.

MarketAxess (MKTX) Q1 Earnings Surpass Estimates — Positive
MKTX Zacks Investment Research — May 07, 2025MarketAxess (MKTX) came out with quarterly earnings of $1.87 per share, beating the Zacks Consensus Estimate of $1.82 per share. This compares to earnings of $1.92 per share a year ago.
